Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of January 22, 2025, Celldex Therapeutics (CLDX) has a market cap of $1.61 billion USD. According to our data, Celldex Therapeutics is ranked No.4497 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Jan 22, 2025 | $1.61 B |
-4.08%
|
| Dec 31, 2024 | $1.68 B |
-36.28%
|
| Dec 29, 2023 | $2.63 B |
-11.02%
|
| Dec 30, 2022 | $2.96 B |
15.35%
|
| Dec 31, 2021 | $2.56 B |
120.55%
|
| Dec 31, 2020 | $1.16 B |
685.65%
|
| Dec 31, 2019 | $0.15 B |
-25.67%
|
| Dec 31, 2018 | $0.20 B |
-92.96%
|
| Dec 29, 2017 | $2.83 B |
-19.77%
|
| Dec 30, 2016 | $3.52 B |
-77.42%
|
| Dec 31, 2015 | $15.60 B |
-14.08%
|
| Dec 31, 2014 | $18.16 B |
-24.62%
|
| Dec 31, 2013 | $24.09 B |
260.80%
|
| Dec 31, 2012 | $6.68 B |
158.08%
|
| Dec 30, 2011 | $2.59 B |
-36.89%
|
| Dec 31, 2010 | $4.10 B |
-11.78%
|
| Dec 31, 2009 | $4.65 B |
-41.04%
|
| Dec 31, 2008 | $7.88 B |
32.00%
|
| Dec 31, 2007 | $5.97 B |
-62.69%
|
| Dec 29, 2006 | $16.00 B |
-28.72%
|
| Dec 30, 2005 | $22.45 B |
-6.47%
|
| Dec 31, 2004 | $24.00 B |
-26.64%
|
| Dec 31, 2003 | $32.72 B |
142.48%
|
| Dec 31, 2002 | $13.49 B |
-71.82%
|
| Dec 31, 2001 | $47.89 B |
-41.67%
|
| Dec 29, 2000 | $82.10 B |
178.48%
|
| Dec 31, 1999 | $29.48 B |
41.07%
|
| Dec 31, 1998 | $20.90 B |
-28.21%
|
| Dec 31, 1997 | $29.11 B |
50.00%
|
| Dec 31, 1996 | $19.41 B |
-48.00%
|
| Dec 29, 1995 | $37.32 B |
25.00%
|
| Dec 30, 1994 | $29.85 B |
-67.74%
|
| Dec 31, 1993 | $92.55 B |
5.08%
|
| Dec 31, 1992 | $88.07 B |
-32.95%
|
| Dec 31, 1991 | $131.36 B |
274.47%
|
| Dec 31, 1990 | $35.08 B |
-41.25%
|
| Dec 29, 1989 | $59.71 B |
150.00%
|
| Dec 30, 1988 | $23.88 B |
-33.33%
|
| Dec 31, 1987 | $35.83 B |
-11.11%
|
| Dec 31, 1986 | $40.30 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Regeneron Pharmaceuticals
REGN
|
$74.73 B |
1.236 B
|
USA
|
 Exelixis
EXEL
|
$9.39 B |
0.000 M
|
USA
|
 Incyte
INCY
|
$13.95 B |
-0.000 M
|
USA
|
 BioMarin Pharmaceutical
BMRN
|
$11.82 B |
0.000 M
|
USA
|
 Alnylam Pharmaceuticals
ALNY
|
$34.38 B |
-0.000 M
|
USA
|
 Blueprint Medicines
BPMC
|
$7.06 B |
-0.000 M
|
USA
|
 Sarepta Therapeutics
SRPT
|
$11.09 B |
0.000 M
|
USA
|
 Ionis Pharmaceuticals
IONS
|
$5.13 B |
-0.000 M
|
USA
|
 Vertex Pharmaceuticals
VRTX
|
$110.22 B |
0.001 M
|
USA
|
 Amgen
AMGN
|
$146.98 B |
0.004 M
|
USA
|
 Gilead Sciences
GILD
|
$115.95 B |
0.002 M
|
USA
|
 Biogen
BIIB
|
$20.80 B |
0.000 M
|
USA
|
| Market Cap | = | CLDX Stock Price | * | CLDX Shares Outstanding |
| = | $24.24 | * | 66.34 M | |
| = | $1.61 B |